Recent Advances on the Roles of NO in Cancer and Chronic Inflammatory Disorders
Journal:
Current Medicinal Chemistry
Volume:
16
Page:
2373-2394
Author(s):
Jagat R. Kanwar, Rupinder K. Kanwar, Hannah Burrow and Sara Baratchi
p53-Induced Apoptosis and Inhibitors of p53
Journal:
Current Medicinal Chemistry
Volume:
16
Page:
2627-2640
Author(s):
Surendra Kumar Nayak, Paramjit Singh Panesar and Harish Kumar
ADAM9 as a Potential Target Molecule in Cancer
Journal:
Current Pharmaceutical Design
Volume:
15
Page:
2282-2287
Author(s):
Lucie Peduto
Targeting ADAM12 in Human Disease: Head, Body or Tail?
Journal:
Current Pharmaceutical Design
Volume:
15
Page:
2300-2310
Author(s):
J. Jacobsen and U. M. Wewer
ADAM28 as a Target for Human Cancers
Journal:
Current Pharmaceutical Design
Volume:
15
Page:
2349-2358
Author(s):
Satsuki Mochizuki and Yasunori Okada
Defining the Role of Integrin αvβ6 in Cancer
Journal:
Current Drug Targets
Volume:
10
Page:
645-652
Author(s):
A. Bandyopadhyay and S. Raghavan
Targeting Rho GTPases by Peptidic Structures
Journal:
Current Pharmaceutical Design
Volume:
15
Page:
2481-2487
Author(s):
Filippo Marchioni and Yi Zheng
Role of Phase II Drug Metabolizing Enzymes in Cancer Chemoprevention
Journal:
Current Drug Metabolism
Volume:
10
Page:
595-616
Author(s):
Snehasis Jana and Sandhya Mandlekar
Future Challenges for Microsomal Transport Protein Inhibitors
Journal:
Current Vascular Pharmacology
Volume:
7
Page:
277-286
Author(s):
Anthony S. Wierzbicki, Tim Hardman and William T. Prince
Discovery of Novel CYP17 Inhibitors for the Treatment of Prostate Cancer with Structure-Based Drug Design
Journal:
Letters in Drug Design & Discovery
Volume:
6
Page:
337-344
Author(s):
Pelin Armutlu, Muhuttin Emre Ozdemir, Sule Ozdas, Ibrahim Halil Kavakli and Metin Turkay